Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 125, Issue 14
April 2 2015
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Recurrent pregnancy loss: drop the heparin needles…
Clinical Trials & Observations
Marc A. Rodger
View Articletitled, Recurrent pregnancy loss: drop the heparin needles…
INSIDE BLOOD COMMENTARY
Endogenous miR-29a regulates HSC function in mammals
Ryan M. O’Connell
View Articletitled, Endogenous <em>miR-29a</em> regulates HSC function in mammals
INSIDE BLOOD COMMENTARY
Platelet biogenesis wears silkworm cocoons
Koji Eto
View Articletitled, Platelet biogenesis wears silkworm cocoons
INSIDE BLOOD COMMENTARY
Ironing out the role of Toll-like receptors
Karin E. Finberg
View Articletitled, Ironing out the role of Toll-like receptors

PERSPECTIVES

Established and theoretical factors to consider in assessing the red cell storage lesion
James C. Zimring
View Articletitled, Established and theoretical factors to consider in assessing the red cell storage lesion

EVIDENCE-BASED FOCUSED REVIEW

The role of thrombolytic therapy in pulmonary embolism
Clinical Trials & Observations
Tzu-Fei Wang,Alessandro Squizzato,Francesco Dentali,Walter Ageno
View Articletitled, The role of thrombolytic therapy in pulmonary embolism
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial
Clinical Trials & Observations
Elisabeth Pasquier,Luc de Saint Martin,Caroline Bohec,Céline Chauleur,Florence Bretelle,Gisèle Marhic,Grégoire Le Gal,Véronique Debarge,Frédéric Lecomte,Christine Denoual-Ziad,Véronique Lejeune-Saada,Serge Douvier,Michel Heisert,Dominique Mottier
View Articletitled, Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial

HEMATOPOIESIS AND STEM CELLS

miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a
Wenhuo Hu,James Dooley,Stephen S. Chung,Dhruva Chandramohan,Luisa Cimmino,Siddhartha Mukherjee,Christopher E. Mason,Bart de Strooper,Adrian Liston,Christopher Y. Park
View Articletitled, <em>miR-29a</em> maintains mouse hematopoietic stem cell self-renewal by regulating <em>Dnmt3a</em>
Supplemental data

IMMUNOBIOLOGY

The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses
Mir Munir A. Rahim,Peter Chen,Amelia N. Mottashed,Ahmad Bakur Mahmoud,Midhun J. Thomas,Qinzhang Zhu,Colin G. Brooks,Vicky Kartsogiannis,Matthew T. Gillespie,James R. Carlyle,Andrew P. Makrigiannis
View Articletitled, The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses
Supplemental data

LYMPHOID NEOPLASIA

Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1
Jiun-Han Lin,Ju-Yin Lin,Ya-Ching Chou,Mei-Ru Chen,Te-Huei Yeh,Chung-Wu Lin,Sue-Jane Lin,Ching-Hwa Tsai
View Articletitled, Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1
Supplemental data
A practical approach to the diagnosis of systemic amyloidoses
Carlos Fernández de Larrea,Laura Verga,Patrizia Morbini,Catherine Klersy,Francesca Lavatelli,Andrea Foli,Laura Obici,Paolo Milani,Gian Luca Capello,Marco Paulli,Giovanni Palladini,Giampaolo Merlini
View Articletitled, A practical approach to the diagnosis of systemic amyloidoses

MYELOID NEOPLASIA

Morgana acts as an oncosuppressor in chronic myeloid leukemia
Augusta Di Savino,Cristina Panuzzo,Stefania Rocca,Ubaldo Familiari,Rocco Piazza,Sabrina Crivellaro,Giovanna Carrà,Roberta Ferretti,Federica Fusella,Emilia Giugliano,Annalisa Camporeale,Irene Franco,Barbara Miniscalco,Juan Carlos Cutrin,Emilia Turco,Lorenzo Silengo,Emilio Hirsch,Giovanna Rege-Cambrin,Carlo Gambacorti-Passerini,Pier Paolo Pandolfi,Mauro Papotti,Giuseppe Saglio,Guido Tarone,Alessandro Morotti,Mara Brancaccio
View Articletitled, Morgana acts as an oncosuppressor in chronic myeloid leukemia
Supplemental data

PLATELETS AND THROMBOPOIESIS

Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
Christian A. Di Buduo,Lindsay S. Wray,Lorenzo Tozzi,Alessandro Malara,Ying Chen,Chiara E. Ghezzi,Daniel Smoot,Carla Sfara,Antonella Antonelli,Elise Spedden,Giovanna Bruni,Cristian Staii,Luigi De Marco,Mauro Magnani,David L. Kaplan,Alessandra Balduini
View Articletitled, Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia
Claudia Guida,Sandro Altamura,Felix A. Klein,Bruno Galy,Michael Boutros,Artur J. Ulmer,Matthias W. Hentze,Martina U. Muckenthaler
View Articletitled, A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia
Supplemental data

THROMBOSIS AND HEMOSTASIS

Both platelet- and endothelial cell–derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis
Freda H. Passam,Lin Lin,Srila Gopal,Jack D. Stopa,Lola Bellido-Martin,Mingdong Huang,Barbara C. Furie,Bruce Furie
View Articletitled, Both platelet- and endothelial cell–derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis
Supplemental data
Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury
Hala Chaaban,Ravi S. Keshari,Robert Silasi-Mansat,Narcis I. Popescu,Padmaja Mehta-D’Souza,Yow-Pin Lim,Florea Lupu
View Articletitled, Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury
Supplemental data
Crucial role for the VWF A1 domain in binding to type IV collagen
Veronica H. Flood,Abraham C. Schlauderaff,Sandra L. Haberichter,Tricia L. Slobodianuk,Paula M. Jacobi,Daniel B. Bellissimo,Pamela A. Christopherson,Kenneth D. Friedman,Joan Cox Gill,Raymond G. Hoffmann,Robert R. Montgomery,the Zimmerman Program Investigators
View Articletitled, Crucial role for the VWF A1 domain in binding to type IV collagen

BLOOD WORK

“Atypical” macrophages
Jonathan Bloch,Sabine Blum
View Articletitled, “Atypical” macrophages

CORRESPONDENCE

Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy
Martin F. M. de Rooij,Annemieke Kuil,Arnon P. Kater,Marie José Kersten,Steven T. Pals,Marcel Spaargaren
View Articletitled, Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy
Supplemental data
CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation
Irina Bonzheim,Barbara Mankel,Peter Klapthor,Janine Schmidt,Tanja Hinrichsen,Oliver Wachter,Falko Fend,Leticia Quintanilla-Martinez
View Articletitled, <em>CALR-</em>mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent <em>CALR</em> mutation and <em>BCR-AB</em><em>L</em> translocation
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group
Annamaria Cseh,Charlotte M. Niemeyer,Ayami Yoshimi,Michael Dworzak,Henrik Hasle,Marry M. van den Heuvel-Eibrink,Franco Locatelli,Riccardo Masetti,Markus Schmugge,Ute Groß-Wieltsch,Andrea Candás,Andreas E. Kulozik,Lale Olcay,Meinolf Suttorp,Ingrid Furlan,Brigitte Strahm,Christian Flotho
View Articletitled, Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals